Robert W. Baird reiterated their outperform rating on shares of Dentsply International Inc. (NASDAQ:XRAY) in a research report report published on Tuesday morning. Robert W. Baird currently has a $67.00 price target on the stock, down from their previous price target of $69.00.

Other equities analysts have also recently issued reports about the company. Credit Suisse Group AG restated a buy rating on shares of Dentsply International in a report on Sunday, June 26th. Piper Jaffray Cos. reaffirmed a buy rating on shares of Dentsply International in a research report on Monday, June 27th. Bank of America Corp. began coverage on Dentsply International in a research report on Monday, September 12th. They set a buy rating and a $70.00 target price on the stock. Jefferies Group reaffirmed a buy rating on shares of Dentsply International in a research report on Wednesday, August 17th. Finally, Zacks Investment Research lowered Dentsply International from a buy rating to a hold rating in a research report on Monday, August 8th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. The company currently has an average rating of Buy and an average price target of $66.91.

Analyst Recommendations for Dentsply International (NASDAQ:XRAY)

Shares of Dentsply International (NASDAQ:XRAY) traded up 0.15% on Tuesday, hitting $58.99. 139,309 shares of the stock traded hands. Dentsply International has a 1-year low of $52.73 and a 1-year high of $65.83. The stock has a 50 day moving average of $60.15 and a 200-day moving average of $61.43.

Dentsply International (NASDAQ:XRAY) last posted its quarterly earnings results on Friday, August 5th. The company reported $0.76 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.70 by $0.06. The firm had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.03 billion. Dentsply International had a return on equity of 9.18% and a net margin of 11.99%. The company’s revenue for the quarter was up 46.4% compared to the same quarter last year. During the same period in the prior year, the business earned $0.73 EPS. On average, equities analysts predict that Dentsply International will post $2.76 earnings per share for the current fiscal year.

The business also recently announced a dividend, which will be paid on Friday, October 14th. Shareholders of record on Friday, September 30th will be paid a $0.0775 dividend. The ex-dividend date is Wednesday, September 28th. Dentsply International’s dividend payout ratio is currently 14.49%.

In other Dentsply International news, SVP Maureen J. Macinnis sold 17,650 shares of the firm’s stock in a transaction dated Tuesday, August 23rd. The stock was sold at an average price of $60.61, for a total value of $1,069,766.50. Following the sale, the senior vice president now owns 19,630 shares of the company’s stock, valued at approximately $1,189,774.30. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, SVP Maureen J. Macinnis sold 45,100 shares of the firm’s stock in a transaction dated Thursday, August 25th. The shares were sold at an average price of $60.55, for a total value of $2,730,805.00. Following the completion of the sale, the senior vice president now directly owns 36,730 shares in the company, valued at approximately $2,224,001.50. The disclosure for this sale can be found here. 2.20% of the stock is owned by company insiders.

Hedge funds have recently added to or reduced their stakes in the stock. Checchi Capital Advisers LLC boosted its stake in Dentsply International by 2.1% in the second quarter. Checchi Capital Advisers LLC now owns 2,007 shares of the company’s stock valued at $125,000 after buying an additional 41 shares during the last quarter. Global X Management Co. LLC boosted its stake in Dentsply International by 110.1% in the second quarter. Global X Management Co. LLC now owns 3,169 shares of the company’s stock valued at $197,000 after buying an additional 1,661 shares during the last quarter. Evercore Wealth Management LLC boosted its stake in Dentsply International by 12.6% in the second quarter. Evercore Wealth Management LLC now owns 3,204 shares of the company’s stock valued at $199,000 after buying an additional 358 shares during the last quarter. Mizuho Asset Management Co. Ltd. boosted its stake in Dentsply International by 170.4% in the second quarter. Mizuho Asset Management Co. Ltd. now owns 3,228 shares of the company’s stock valued at $200,000 after buying an additional 2,034 shares during the last quarter. Finally, Carnick & Kubik LLC acquired a new stake in Dentsply International during the first quarter valued at $201,000. 94.58% of the stock is currently owned by hedge funds and other institutional investors.

Dentsply International Company Profile

DENTSPLY SIRONA Inc, formerly DENTSPLY International Inc, designs, develops, manufactures and markets a range of consumable dental products for the professional dental market. The Company also manufactures and markets consumable medical device products consisting mainly of urological catheters and certain surgical products.

5 Day Chart for NASDAQ:XRAY

Receive News & Stock Ratings for Dentsply International Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dentsply International Inc. and related stocks with our FREE daily email newsletter.